Glioblastoma and Individualized Therapies
ConditionGlioma, Malignant
Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexAll
AgeNot listed
SponsorZentrum fur Humangenetik Tuebingen
About this trial
The treatment of patients with World Health Organization (WHO) grade 4 malignant glioma has not seen any significant breakthrough the past years. Following surgery and radio / chemotherapy patients still experience a very high recurrence risk and the prognosis is dismal. The investigators observed patients with grade IV malignant glioma receiving individualized treatment based on their molecular profile including fully personalized vaccines.
Eligibility criteria
Qualifiers
malignant glioma, IDH WT
Disqualifiers
na
Trial design
Treatments tested in this trial
- Vaccination
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov